» Articles » PMID: 16293610

Specialization, Kinetics, and Repertoire of Type 1 Interferon Responses by Human Plasmacytoid Predendritic Cells

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2005 Nov 19
PMID 16293610
Citations 131
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies suggest plasmacytoid predendritic cells (pDCs) and myeloid dendritic cells (mDCs) have the functional plasticity to produce similar amounts of type 1 interferons (IFNs) and interleukin-12 (IL-12), challenging the concept and existence of DC subsets with distinct function. In this study, we demonstrate that previous studies showed human pDCs produce large amounts of IL-12 because of contaminating mDCs. Using highly purified human DC subsets, we found that although pDCs make 300 times more IFN-alpha than mDCs and mDCs make 13 times more IL-12 p70 than pDCs in response to all the toll-like receptor ligands and CD40 ligands, pDCs rapidly make large amounts of IFN-alpha within the first 12 hours of activation and become refractory to further stimulation. pDCs preferentially expressed the transcriptional factors critical for type 1 IFN, but not for IL-12 transcription, and they dedicated 60% of new transcriptional activity to make 19 type 1 IFN subtypes. This study provides formal proof that the plasticity of DC subsets is limited and that different DC subsets evolve to perform distinct functions in linking innate and adaptive immunity.

Citing Articles

Dendritic cell maturation in cancer.

Moon C, Belabed M, Park M, Mattiuz R, Puleston D, Merad M Nat Rev Cancer. 2025; .

PMID: 39920276 DOI: 10.1038/s41568-024-00787-3.


A novel immunomodulating peptide with potential to complement oligodeoxynucleotide-mediated adjuvanticity in vaccination strategies.

Agrez M, Chandler C, Thurecht K, Fletcher N, Liu F, Subramaniam G Sci Rep. 2024; 14(1):26737.

PMID: 39501043 PMC: 11538426. DOI: 10.1038/s41598-024-78150-7.


The role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond.

Ngo C, Garrec C, Tomasello E, Dalod M Cell Mol Immunol. 2024; 21(9):1008-1035.

PMID: 38777879 PMC: 11364676. DOI: 10.1038/s41423-024-01167-5.


Unraveling IFN-I response dynamics and TNF crosstalk in the pathophysiology of systemic lupus erythematosus.

Van Eyndhoven L, Chouri E, Matos C, Pandit A, Radstake T, Broen J Front Immunol. 2024; 15:1322814.

PMID: 38596672 PMC: 11002168. DOI: 10.3389/fimmu.2024.1322814.


Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer.

Tiberio L, Laffranchi M, Zucchi G, Salvi V, Schioppa T, Sozzani S Front Immunol. 2024; 15:1360291.

PMID: 38504978 PMC: 10948453. DOI: 10.3389/fimmu.2024.1360291.